# OnCo record paper-keynote-042-j-clin-oncol-2023-update (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-keynote-042-j-clin-oncol-2023-update/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-keynote-042-j-clin-oncol-2023-update" ;
  schema:name "Five-Year Outcomes With Pembrolizumab Versus Chemotherapy as First-Line Therapy in Patients With Non-Small-Cell Lung Cancer and Programmed Death Ligand-1 Tumor Proportion Score ≥ 1% in the KEYNOTE-042 Study"@en ;
  schema:description "Later report from the KEYNOTE-042 trial registered as NCT02220894, in Journal of Clinical Oncology (2023); its title describes an updated or longer-term analysis."@en ;
  schema:url <https://onco.cc/key-papers/paper-keynote-042-j-clin-oncol-2023-update/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/jco.21.02885>, <https://pubmed.ncbi.nlm.nih.gov/36306479/>, <https://europepmc.org/article/MED/36306479>, <https://clinicaltrials.gov/study/NCT02220894> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1200/jco.21.02885> ;
  schema:datePublished "2023"^^xsd:gYear ;
  schema:author "de Castro G, Kudaba I, Wu YL, et al." ;
  onco:trials <https://onco.cc/trials/keynote-042/> ;
  onco:journals <https://onco.cc/journals/jco/> .